 | Webcast Q4 2009 Hospira Earnings Conference Call (Replay) 02/04/10 at 9:00 a.m. ET |
Corporate Profile
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has more than 14,000 employees worldwide. In 2008, Hospira generated approximately $3.6 billion in sales. Shareholder Information ExchangeThe common stock is listed on the New York Stock Exchange under the symbol "HSP." Transfer Agent Computershare Investor Services P.O. Box 43078 Providence, RI 02940-3078 800-821-1238 www.computershare.com https://www-us.computershare.com/investor/contactus For shareholders of Mayne Pharma stock – click here for information regarding Mayne Pharma shares. Hospira Investor Relations Contact Information For questions regarding Investor Relations, please contact Hospira through our online investor information Email.Hospira Mailing Address: |
Shareholder E-Delivery
Are you a Hospira shareholder? If so, you can elect to receive your annual report, proxy statement and other investor-related materials online, reducing the amount of mailings you receive from us. Using Shareholder E-Delivery also promotes less paper usage, a more environmentally friendly practice, and helps reduce company costs. If this is an option that interests you, sign up today! |
| |||||||||||||
| ||||||||||||||
|
|  | ||||||||||||
| ||||||||||||||
|
| | ||||||||||||
| ||||||||||||||
|
| | ||||||||||||
| ||||||||||||||
| ||||||||||||||
